TAC Versus TCX as Adjuvant Treatment for Node-Positive Her2-Negative Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Docetaxel, Doxorubicin, Cyclophosphamide|DRUG: Docetaxel, Cyclophosphamide, Capecitabine
Sponsor: Peking Union Medical College Hospital